You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

olaparib

Showing 1 - 25 of 187
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer, GastroEsophageal Cancer Trial in Aurora, Colorado Springs, Highlands Ranch (Pembrolizumab, Olaparib,

Not yet recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Aurora, Colorado
  • +2 more
May 19, 2022

Prostate Cancer Trial in Lexington (biological, drug, radiation)

Not yet recruiting
  • Prostate Cancer
  • Pembrolizumab
  • +3 more
  • Lexington, Kentucky
    University of Kentucky
Oct 3, 2022

Pancreatic Acinar Cell Carcinoma Trial run by the National Cancer Institute (NCI) (Olaparib)

Recruiting
  • Pancreatic Acinar Cell Carcinoma
  • Olaparib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 17, 2022

Metastatic Breast Cancer Trial in Taipei City, Taipei, Yuanlin (Olaparib, Chemotherapy drug)

Recruiting
  • Metastatic Breast Cancer
  • Olaparib
  • Chemotherapy drug
  • Taipei City, Please Select, Taiwan
  • +2 more
Nov 27, 2022

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Olaparib
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 23, 2022

Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

Not yet recruiting
  • Recurrent Metastatic Melanoma
  • +3 more
  • Olaparib
  • Boston, Massachusetts
  • +1 more
Jul 29, 2022

Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer Trial (AsiDNA, Olaparib)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • +2 more
  • (no location specified)
Jan 17, 2023

Cancer Trial in Amsterdam, Nijmegen, Rotterdam (Olaparib, Cobicistat)

Recruiting
  • Cancer
  • Amsterdam, Netherlands
  • +2 more
Dec 29, 2021

Ovarian Cancer Trial in Toronto (Cediranib, Olaparib)

Completed
  • Ovarian Cancer
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 3, 2022

Cervical Cancer Trial in Hidaka (Pembrolizumab, Olaparib)

Active, not recruiting
  • Cervical Cancer
  • Hidaka, Saitama, Japan
    Saitama Medical Uiversity International Medical Center
Aug 8, 2022

Glioblastoma, Recurrent Glioblastoma Trial in Boston (Pembrolizumab, Olaparib, Temozolomide)

Not yet recruiting
  • Glioblastoma
  • Recurrent Glioblastoma
  • Boston, Massachusetts
  • +2 more
Jul 14, 2022

Biliary Tract Cancer, DNA Damage Repair Deficiency Trial in Seoul (Durvalumab, Olaparib)

Recruiting
  • Biliary Tract Cancer
  • DNA Damage Repair Deficiency
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 8, 2022

Triple Negative Breast Cancer Trial in Shanghai (Cisplatin, Nab-paclitaxel, Pembrolizumab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 18, 2022

Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

Not yet recruiting
  • Gastroenteropancreatico Tumors
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Sarcoma, Sarcoma Metastatic Trial in Ann Arbor (Olaparib, Trabectedin)

Recruiting
  • Sarcoma
  • Sarcoma Metastatic
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Dec 15, 2021

Carcinoma, Ovarian Epithelial Trial in Hidaka (pembrolizumab, olaparib, bevacizumab)

Recruiting
  • Carcinoma, Ovarian Epithelial
  • pembrolizumab
  • +5 more
  • Hidaka, Saitama, Japan
    Saitama Medical Uiversity International Medical Center
Apr 25, 2022

Prostate Cancer, Prostate Carcinoma, Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou (Olaparib)

Recruiting
  • Prostate Cancer
  • +2 more
  • Olaparib
  • Guangzhou, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Feb 20, 2022

Glioma, Cholangiocarcinoma, Solid Tumor Trial in Toronto (Olaparib, Durvalumab)

Recruiting
  • Glioma
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Nov 29, 2021

Metastatic Pancreatic Cancer Trial in Baltimore (Nab-paclitaxel, Gemcitabine, Cisplatin)

Recruiting
  • Metastatic Pancreatic Cancer
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Mar 14, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Chapel Hill, Charleston (biological, drug, radiation)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Pembrolizumab
  • +3 more
  • Chapel Hill, North Carolina
  • +1 more
Aug 9, 2022

Pancreatic Cancer Trial (Pembrolizumab, Olaparib)

Not yet recruiting
  • Pancreatic Cancer
  • (no location specified)
Oct 21, 2021

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Recruiting
  • Locally Advanced Leiomyosarcoma
  • +5 more
  • Olaparib
  • +3 more
  • New York, New York
    Columbia University/Herbert Irving Cancer Center
Jan 4, 2023

EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

Recruiting
  • EGFR-Mutated Non-Small-Cell Lung Carcinoma
  • Small Cell/Neuroendocrine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 20, 2022

Prostate Trial in United States (Olaparib)

Recruiting
  • Prostate
  • Olaparib
  • Baltimore, Maryland
  • +3 more
Feb 14, 2022

TNBC - Triple-Negative Breast Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (olaparib, Durvalumab)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • +2 more
  • (no location specified)
Jan 12, 2022